Richard Wilson

8PUBLICATIONS
79CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersSolid tumoursCounselling psychologyCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 25, 2025
MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance.

Mark White, Megan L Mills, Laura M Millett

|Mar 21, 2024
Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis: the EASI-SWITCH RCT.

Vicky Coyle, Caroline Forde, Richard Adams

|Jul 07, 2023
Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: a sub-study of the Add-Aspirin trial.

Nalinie Joharatnam-Hogan, Duaa Hatem, Fay H Cafferty

|May 14, 2022
A first-in-human Phase I dose-escalation trial of the novel therapeutic peptide, ALM201, demonstrates a favourable safety profile in unselected patients with ovarian cancer and other advanced solid tumours.

Aya El Helali, Ruth Plummer, Gordon C Jayson

|Feb 22, 2022
Reply to A. Kurreck et al and M.S. Copur et al.

Richard Adams, Richard Wilson, Louise Brown

|Jan 27, 2022
Experiences of running a stratified medicine adaptive platform trial: Challenges and lessons learned from 10 years of the FOCUS4 trial in metastatic colorectal cancer.

Louise C Brown, Janet Graham, David Fisher

Pageof 2

Frequent Collaborators

5 joint publications

Richard Adams

4 joint publications

Louise C Brown

3 joint publications

Richard Kaplan

3 joint publications

Timothy S Maughan